Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis.

Source:http://linkedlifedata.com/resource/pubmed/id/18097026

J. Immunol. 2008 Jan 1 180 1 249-60

Download in:

View as

General Info

PMID
18097026